Chen, Ting
NYU Langone Health · NYU Langone’s Laura and Isaac Perlmutter Cancer Center
18 papers on CoChatORCID 0000-0003-1725-7956
Most cited papers
- Verified
Integrative functional genomic analysis of human brain development and neuropsychiatric risks
Li, M., Santpere, G., Imamura Kawasawa, Y., Evgrafov, O. V., Gulden, F. O., Pochareddy, S., Sunkin, S. M., Li, Z., Shin, Y., Zhu, Y., et al. (2018) · Science
Genetics and Neurodevelopmental DisordersGenomics and Chromatin Dynamics
Cited by 810
- Verified
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Deng, J., Wang, E. S., Jenkins, R. W., Li, S., Dries, R., Yates, K., Chhabra, S., Huang, W., Liu, H., Aref, A. R., et al. (2018) · Cancer Discovery
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 770
- Verified
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kurppa, K. J., Liu, Y., To, C., Zhang, T., Fan, M., Vajdi, A., Knelson, E. H., Xie, Y., Lim, K., Cejas, P., et al. (2020) · Cancer Cell
Hippo pathway signaling and YAP/TAZLung Cancer Treatments and Mutations
Cited by 475
- Verified
Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
Robichaux, J. P., Elamin, Y. Y., Tan, Z., Carter, B. W., Zhang, S., Liu, S., Li, S., Chen, T., Poteete, A., Estrada-Bernal, A., et al. (2018) · Nature Medicine
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 468
- Verified
LKB1 loss links serine metabolism to DNA methylation and tumorigenesis
Kottakis, F., Nicolay, B. N., Roumane, A., Karnik, R., Gu, H., Nagle, J. M., Boukhali, M., Hayward, M. C., Li, Y. Y., Chen, T., et al. (2016) · Nature
Epigenetics and DNA MethylationCancer, Hypoxia, and Metabolism
Cited by 348
- Verified
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling
Fedele, C., Li, S., Teng, K. W., Foster, C. J. R., Peng, D., Ran, H., Mita, P., Geer, M. J., Hattori, T., Koide, A., et al. (2021) · Journal of Experimental Medicine
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 265
- Verified
Autophagy Inhibition Potentiates the Anti-angiogenic Property of Multikinase Inhibitor Anlotinib through JAK2/STAT3/VEGFA Signaling in Non-small Cell Lung Cancer Cells
Liang, L., Hui, K., Hu, C., Wen, Y., Yang, S., Zhu, P., Wang, L., Xia, Y., Qiao, Y., Sun, W., et al. (2019) · Journal of Experimental & Clinical Cancer Research
Autophagy in Disease and TherapyAngiogenesis and VEGF in Cancer
Cited by 187
- Verified
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer
Deng, J., Thennavan, A., Dolgalev, I., Chen, T., Li, J., Marzio, A., Poirier, J. T., Peng, D. H., Bulatovic, M., Mukhopadhyay, S., et al. (2021) · Nature Cancer
Cancer Immunotherapy and BiomarkersAutophagy in Disease and Therapy
Cited by 140
- Verified
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Zhang, H., Fillmore Brainson, C., Koyama, S., Redig, A. J., Chen, T., Li, S., Gupta, M., Garcia-de-Alba, C., Paschini, M., Herter-Sprie, G. S., et al. (2017) · Nature Communications
Epigenetics and DNA MethylationCancer Cells and Metastasis
Cited by 127
- Verified
SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells
George, J. A., Chen, T., & Taylor, C. C. (2005) · Cancer Research
Drug Transport and Resistance MechanismsOvarian cancer diagnosis and treatment
Cited by 78
- Verified
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS
Kitajima, S., Asahina, H., Chen, T., Guo, S., Quiceno, L. G., Cavanaugh, J. D., Merlino, A. A., Tange, S., Terai, H., Kim, J. W., et al. (2018) · Cancer Cell
Melanoma and MAPK PathwaysHippo pathway signaling and YAP/TAZ
Cited by 75
- Verified
Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer
Li, S., Liu, S., Deng, J., Akbay, E. A., Hai, J., Ambrogio, C., Zhang, L., Zhou, F., Jenkins, R. W., Adeegbe, D. O., et al. (2018) · Clinical Cancer Research
Lung Cancer Treatments and MutationsMelanoma and MAPK Pathways
Cited by 67
- Verified
Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib
Han, H., Li, S., Chen, T., Fitzgerald, M., Liu, S., Peng, C., Tang, K. H., Cao, S., Chouitar, J., Wu, J., et al. (2021) · Cancer Research
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 57
- Verified
Structural and molecular basis of choline uptake into the brain by FLVCR2
Cater, R. J., Mukherjee, D., Gil-Iturbe, E., Erramilli, S. K., Chen, T., Koo, K., Santander, N., Reckers, A., Kloss, B., Gawda, T., et al. (2024) · Nature
Drug Transport and Resistance MechanismsBarrier Structure and Function Studies
Cited by 45
- Verified
Structural and molecular basis of choline uptake into the brain by FLVCR2
Cater, R. J., Mukherjee, D., Iturbe, E. G., Erramilli, S. K., Chen, T., Koo, K., Grez, N. S., Reckers, A., Kloss, B., Gawda, T., et al. (2023) · Nature
Drug Transport and Resistance MechanismsBarrier Structure and Function Studies
Cited by 45
- Verified
Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays
Stoiljkovic, M., Leventhal, L., Chen, A., Chen, T., Driscoll, R., Flood, D., Hodgdon, H., Hurst, R., Nagy, D., Piser, T., et al. (2015) · Biochemical Pharmacology
Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research
Cited by 29
- Verified
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11 -Mutant Tumors to Anti–PD-1 Immunotherapy
Ahronian, L. G., Sahu, S., Zhang, M., Patel, A. S., Geng, K., Bhattacharya, R., Falchook, G. S., Goldman, J. W., Spira, A. I., Punekar, S. R., et al. (2025) · Cancer Research
Cancer Immunotherapy and BiomarkersHistone Deacetylase Inhibitors Research
Cited by 9
- Verified
Intratympanic lidocaine as a potent remedy for tinnitus in sudden sensorineural hearing loss: a double-blind, randomized clinical trial
Zhang, D., Li, D., Chen, T., Feng, X., & Zhang, J. (2024) · Otology & Neurotology
Vestibular and auditory disordersHearing, Cochlea, Tinnitus, Genetics
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free